<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Anti-prothrombin antibodies (aPT) are associated with thrombotic manifestations, and their association with reproductive failure is debatable </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to examine whether aPT could induce <z:mp ids='MP_0005048'>thrombosis</z:mp> and other clinical manifestations of the anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> syndrome (APS) </plain></SENT>
<SENT sid="2" pm="."><plain>Mice were immunized with either prothrombin, beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi>-I (beta2GPI), or beta2GPI followed by prothrombin </plain></SENT>
<SENT sid="3" pm="."><plain>The presence of clinical manifestation of APS, including <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and <z:e sem="disease" ids="C0015951" disease_type="Disease or Syndrome" abbrv="">fetal resorption</z:e> rates, was evaluated in <z:hpo ids='HP_0000001'>all</z:hpo> mice groups compared with nonimmunized mice </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0005048'>Thrombosis</z:mp> was studied in a novel ex-vivo model in which the aorta was sutured for 1 min and the presence or absence of visible <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> was qualitatively evaluated </plain></SENT>
<SENT sid="5" pm="."><plain>Immunized mice developed high autoantibody levels directed towards their immunizing autoantigens </plain></SENT>
<SENT sid="6" pm="."><plain>The groups immunized with beta2GPI or beta2GPI/prothrombin, but not with prothrombin alone, developed prolonged aPTT, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and increased <z:e sem="disease" ids="C0015951" disease_type="Disease or Syndrome" abbrv="">fetal resorption</z:e> rate </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> prothrombin-immunized mice as well as most beta2GPI/prothrombin-immunized mice developed visible <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> within the aorta </plain></SENT>
<SENT sid="8" pm="."><plain>Some beta2GPI immunized mice developed very mild <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>None of the CFA/PBS-injected or the nonimmunized mice developed such <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Active immunization with prothrombin or beta2GPI/prothrombin is associated with prothrombotic activity of blood in an ex-vivo model </plain></SENT>
<SENT sid="11" pm="."><plain>This is the first direct evidence for <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> induction by aPT </plain></SENT>
</text></document>